MENU
+Compare
ENSC
Stock ticker: NASDAQ
AS OF
Jun 11, 04:58 PM (EDT)
Price
$2.09
Change
+$0.05 (+2.45%)
Capitalization
4.9M

ENSC Ensysce Biosciences Forecast, Technical & Fundamental Analysis

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs... Show more

ENSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ENSC with price predictions
Jun 10, 2025

ENSC's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for ENSC turned positive on May 14, 2025. Looking at past instances where ENSC's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 67 cases where ENSC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ENSC advanced for three days, in of 169 cases, the price rose further within the following month. The odds of a continued upward trend are .

ENSC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 10, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ENSC as a result. In of 108 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

ENSC moved below its 50-day moving average on June 09, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ENSC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.606) is normal, around the industry mean (16.771). P/E Ratio (0.019) is within average values for comparable stocks, (60.276). ENSC's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.289). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (262.169).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ENSC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ENSC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ENSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
7946 Ivanhoe Avenue
Phone
+1 858 263-4196
Employees
9
Web
https://www.ensysce.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MBC10.930.33
+3.11%
MasterBrand
RDGT1.140.02
+1.43%
Ridgetech Inc
ARVN7.82-0.01
-0.13%
Arvinas
PODD298.73-6.93
-2.27%
Insulet Corp
RSLS2.46-0.14
-5.38%
ReShape Lifesciences Inc.

ENSC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ENSC has been loosely correlated with MLLCF. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ENSC jumps, then MLLCF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENSC
1D Price
Change %
ENSC100%
-12.66%
MLLCF - ENSC
40%
Loosely correlated
N/A
GNPX - ENSC
26%
Poorly correlated
+3.40%
HNSBF - ENSC
25%
Poorly correlated
N/A
NBY - ENSC
24%
Poorly correlated
+0.30%
ATXS - ENSC
23%
Poorly correlated
-1.38%
More